Home NDC 0093-5731 Oxycodone Hydrochloride
Product NDC 0093-5731
11-digit product format 000935731
Labeler code 0093
Product ID 0093-5731_a5144031-83e4-4330-9c91-38b08b352141
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Oxycodone Hydrochloride
Dosage form TABLET, FILM COATED, EXTENDED RELEASE
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application NDA022272
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2015-10-12
Marketing end 0000-00-00
Substance OXYCODONE HYDROCHLORIDE
Active strength 10 mg/1
Pharmacologic classes Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA schedule CII
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 18 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0093-5731-01 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0093-5731-01 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0093-5731-01 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0093-5731-01 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0093-5731-01 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0093-5731-01 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0093-5731-01 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0093-5731-01 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0093-5731-01 0efc9e666f02…f202fb6c5f17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 7 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022272-001 OXYCONTIN OXYCODONE HYDROCHLORIDE 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 N022272-002 OXYCONTIN OXYCODONE HYDROCHLORIDE 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 N022272-003 OXYCONTIN OXYCODONE HYDROCHLORIDE 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 N022272-004 OXYCONTIN OXYCODONE HYDROCHLORIDE 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 N022272-005 OXYCONTIN OXYCODONE HYDROCHLORIDE 40MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2010-04-05 N022272-006 OXYCONTIN OXYCODONE HYDROCHLORIDE 60MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 N022272-007 OXYCONTIN OXYCODONE HYDROCHLORIDE 80MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05
Orange Book patents# Current patent rows page 1 of 2 · 102 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 8 · 301 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N022272-001 OXYCONTIN 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 OXYCONTIN 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 OXYCONTIN 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-004 OXYCONTIN 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-005 OXYCONTIN 40MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2010-04-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-006 OXYCONTIN 60MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-007 OXYCONTIN 80MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022272-001 OXYCONTIN 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022272-002 OXYCONTIN 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022272-003 OXYCONTIN 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022272-004 OXYCONTIN 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022272-005 OXYCONTIN 40MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2010-04-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022272-006 OXYCONTIN 60MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022272-007 OXYCONTIN 80MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022272-001 OXYCONTIN 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022272-002 OXYCONTIN 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022272-003 OXYCONTIN 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022272-004 OXYCONTIN 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022272-005 OXYCONTIN 40MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2010-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022272-006 OXYCONTIN 60MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022272-007 OXYCONTIN 80MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022272-001 OXYCONTIN 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022272-002 OXYCONTIN 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022272-003 OXYCONTIN 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022272-004 OXYCONTIN 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022272-005 OXYCONTIN 40MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2010-04-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022272-006 OXYCONTIN 60MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022272-007 OXYCONTIN 80MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022272-001 OXYCONTIN 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022272-002 OXYCONTIN 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022272-003 OXYCONTIN 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022272-004 OXYCONTIN 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022272-005 OXYCONTIN 40MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2010-04-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022272-006 OXYCONTIN 60MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022272-007 OXYCONTIN 80MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022272-001 OXYCONTIN 10MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022272-002 OXYCONTIN 15MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022272-003 OXYCONTIN 20MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022272-004 OXYCONTIN 30MG TABLET, EXTENDED RELEASE / ORAL RLD 2010-04-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022272-005 OXYCONTIN 40MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2010-04-05 fd3edfee7708…
Observed Orange Book patent history# Patent history page 1 of 139 · 5,544 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N022272-001 11304908 2027-08-24 Drug product 2022-04-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 11304909 2027-08-24 U-1556 2022-04-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 11964056 2027-08-24 Drug product 2024-04-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 12246094 2027-08-24 Drug product 2025-03-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 12280152 2027-08-24 Drug product 2025-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 8808741 2027-08-24 U-1556 2014-08-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 8894988 2027-08-24 Drug product 2014-11-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 9492389 2027-08-24 Drug product 2016-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 9492391 2027-08-24 U-1556 2016-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 9492392 2027-08-24 Drug product 2016-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 9492393 2027-08-24 U-1556 2016-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 9763933 2027-08-24 Drug product 2017-09-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 9770416 2027-08-24 Drug product 2017-09-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 9775808 2027-08-24 Drug product 2017-10-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-001 8894987 2030-03-29 Drug product 2014-11-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 11304908 2027-08-24 Drug product 2022-04-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 11304909 2027-08-24 U-1556 2022-04-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 11964056 2027-08-24 Drug product 2024-04-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 12246094 2027-08-24 Drug product 2025-03-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 12280152 2027-08-24 Drug product 2025-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 8808741 2027-08-24 U-1556 2014-08-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 8894988 2027-08-24 Drug product 2014-11-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 9492389 2027-08-24 Drug product 2016-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 9492391 2027-08-24 U-1556 2016-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 9492392 2027-08-24 Drug product 2016-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 9492393 2027-08-24 U-1556 2016-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 9763933 2027-08-24 Drug product 2017-09-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 9770416 2027-08-24 Drug product 2017-09-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 9775808 2027-08-24 Drug product 2017-10-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-002 8894987 2030-03-29 Drug product 2014-11-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 11304908 2027-08-24 Drug product 2022-04-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 11304909 2027-08-24 U-1556 2022-04-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 11964056 2027-08-24 Drug product 2024-04-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 12246094 2027-08-24 Drug product 2025-03-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 12280152 2027-08-24 Drug product 2025-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 8808741 2027-08-24 U-1556 2014-08-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 8894988 2027-08-24 Drug product 2014-11-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 9492389 2027-08-24 Drug product 2016-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 9492391 2027-08-24 U-1556 2016-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022272-003 9492392 2027-08-24 Drug product 2016-11-16 84e616aacf4f…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded OXYCODONE HYDROCHLORIDE ACTIVE INGREDIENT C1ENJ2TE6C OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 OXYCODONE ACTIVE MOIETY CD35PMG570 OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 BUTYLATED HYDROXYTOLUENE INACTIVE INGREDIENT 1P9D0Z171K OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 INDIGOTINDISULFONATE SODIUM INACTIVE INGREDIENT D3741U8K7L OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0093-5731-01 00093573101 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-5731-01) 2015-10-12 0000-00-00 No No Current